{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:18:07Z","timestamp":1760833087751,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"crossref","award":["81673303","81373265 and 81373264"],"award-info":[{"award-number":["81673303","81373265 and 81373264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003336","name":"BNSF","doi-asserted-by":"crossref","award":["7162025","7172028"],"award-info":[{"award-number":["7162025","7172028"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PHR","award":["KZ201610025029","KM201710025009"],"award-info":[{"award-number":["KZ201610025029","KM201710025009"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bmcl.2017.10.068","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T00:31:28Z","timestamp":1509150688000},"page":"5114-5118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Docking based design of diastereoisomeric MTCA as GPIIb\/IIIa receptor inhibitor"],"prefix":"10.1016","volume":"27","author":[{"given":"Xiaozhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.10.068_b0005","first-page":"10","article-title":"Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: additional benefit in cardiovascular diseases prevention","volume":"91","author":"Sep\u00falveda","year":"2017","journal-title":"VascPharmacology"},{"key":"10.1016\/j.bmcl.2017.10.068_b0010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/ATVBAHA.115.305378","article-title":"Endothelial PPAR-\u03b3 protects against vascular thrombosis by downregulating P-selectin expression","volume":"35","author":"Jin","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bmcl.2017.10.068_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2017.07.031","article-title":"Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction","volume":"158","author":"Hally","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.bmcl.2017.10.068_b0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jff.2013.10.012","article-title":"Antiplatelet effects of natural bioactive compounds by multiple targets: food and drug interactions","volume":"6","author":"Fuentes","year":"2014","journal-title":"J Funct Foods"},{"key":"10.1016\/j.bmcl.2017.10.068_b0025","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/eurheartj\/ehr373","article-title":"Antiplatelet agents for the treatment and prevention of atherothrombosis","volume":"32","author":"Patrono","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bmcl.2017.10.068_b0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bmcl.2017.10.068_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y12 inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bmcl.2017.10.068_b0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2011.11.088","article-title":"P2Y12 inhibitors adjunctive to primary PCI therapy in STEMI: fighting against the activated platelets","volume":"163","author":"Alexopoulos","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.bmcl.2017.10.068_b0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin-receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bmcl.2017.10.068_b0050","doi-asserted-by":"crossref","first-page":"199S","DOI":"10.1378\/chest.08-0672","article-title":"Antiplatelet drugs: American college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Patrono","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.bmcl.2017.10.068_b0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13197-011-0269-4","article-title":"Role of nutraceuticals in human health","volume":"49","author":"Das","year":"2012","journal-title":"J Food Sci Technol (Mysore)"},{"key":"10.1016\/j.bmcl.2017.10.068_b0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jff.2012.08.007","article-title":"Fucoidans as a natural bioactive ingredient for functional foods","volume":"5","author":"Voa","year":"2013","journal-title":"J Funct Foods"},{"key":"10.1016\/j.bmcl.2017.10.068_b0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.phytochem.2017.07.011","article-title":"Clovamide and clovamide-rich extracts of three trifolium species as antioxidants and moderate antiplatelet agents in vitro","volume":"143","author":"Joanna","year":"2017","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmcl.2017.10.068_b0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jff.2017.02.031","article-title":"Anthocyanin supplementation in alleviating thrombogenesis in overweight and obese population: a randomized, double-blind, placebo-controlled study","volume":"32","author":"Thompson","year":"2017","journal-title":"J Funct Foods"},{"key":"10.1016\/j.bmcl.2017.10.068_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2017.04.009","article-title":"Flavonoids and platelet aggregation: a brief review","volume":"807","author":"Faggio","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2017.10.068_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2016.07.021","article-title":"Advances of blood cell-based drug delibery systems","volume":"96","author":"Sun","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmcl.2017.10.068_b0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejmech.2017.04.023","article-title":"Synthesis and mechanistic evaluation of novel N\u2032-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents","volume":"135","author":"Louren\u00e7o","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0090","first-page":"946","article-title":"Synthesis and biological evaluation of nitric oxide (NO)-hydrogen sulfide (H2S) releasing derivatives of (S)-3-n-butylphthalide as potential antiplatelet agents","volume":"14","author":"Wang","year":"2016","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.bmcl.2017.10.068_b0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bmcl.2017.10.068_b0100","first-page":"1443","article-title":"GPIIb-IIIa receptor in acute coronary syndrome patients presenting with cardiogenic shock and\/or after cardiopulmonary resuscitation","volume":"4","author":"Kanic","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.bmcl.2017.10.068_b0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.redox.2017.05.019","article-title":"HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases","volume":"13","author":"Kung","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.bmcl.2017.10.068_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2016.09.032","article-title":"Design, synthesis and evaluation of novel 2-amino-3-(naphtha-2-yl) propanoic acid derivatives as potent inhibitors of platelet aggregation","volume":"125","author":"Xie","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0115","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejmech.2013.03.056","article-title":"Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb\/IIIa with highly overlapped pharmacophores","volume":"64","author":"Trstenjak","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2017.06.002","article-title":"Isoxazole ring as a useful scaffold in a search for new therapeutic agents","volume":"137","author":"Sysak","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0125","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1016\/j.ejmech.2009.08.002","article-title":"A class of novel N-(3S-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-l-amino acid derivatives: their synthesis, anti-thrombotic activity evaluation, and 3D QSAR analysis","volume":"44","author":"Cheng","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0130","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1016\/j.bmc.2008.09.019","article-title":"(3S)-N-(l-Aminoacyl)-1,2,3,4-tetrahydroisoquinolines, a class of novel antithrombotic agents: synthesis, bioassay, 3D QSAR, and ADME analysis","volume":"16","author":"Zheng","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0135","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.bmc.2006.03.026","article-title":"Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity","volume":"14","author":"Zhao","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2017.10.068_b0140","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1039\/C6TB02705A","article-title":"IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA\/TARGD(S)S in vivo","volume":"5","author":"Wu","year":"2017","journal-title":"J Mater Chem B"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17310697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17310697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:21:06Z","timestamp":1760772066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17310697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0960894X17310697"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.10.068","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docking based design of diastereoisomeric MTCA as GPIIb\/IIIa receptor inhibitor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.10.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}